The dipeptidyl peptidase IV inhibitor vildagliptin suppresses development of neuropathy in diabetic rodents: effects on peripheral sensory nerve function, structure and molecular changes-Reference-Cited by-同舟云学术

The dipeptidyl peptidase IV inhibitor vildagliptin suppresses development of neuropathy in diabetic rodents: effects on peripheral sensory nerve function, structure and molecular changes

Published:2016-01-11 Issue:4 Volume:136 Page:859-870
ISSN:0022-3042
Container-title:Journal of Neurochemistry
language:en
Short-container-title:J. Neurochem.

Author:

Tsuboi Kentaro¹,Mizukami Hiroki¹,Inaba Wataru¹,Baba Masayuki²,Yagihashi Soroku¹

Affiliation:

1. Department of Pathology and Molecular Medicine; Hirosaki University Graduate School of Medicine; Hirosaki Japan

2. Department of Neurology; Aomori Prefectural Hospital; Aomori Japan

Funder

Japanese Ministry of Health, Welfare and Labor

Japanese Ministry of Science, Education, Culture and Sports

Takeda Science Foundation

Novartis Pharma

Novartis

Daiichi Sankyo Company

Ono

Mitsubishi Tanabe and AstraZeneka companies

Kentaro Tsuboi

Hiroki Mizukami

Wataru Inaba - none

Soroku Yagihashi - speaker: Novartis

Ono Pharmaceuticals

Shionogi Pharmaceuticals

Astellas Pharma

AstraZeneca

Meso Scale Diagnostics

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jnc.13439/fullpdf

Reference40 articles.

1. Improved meal-related beta-cell function and insulin sensitivity by the dipeptidyl peptidase-IV inhibitor vildagliptin in metformin-treated patients with type 2 diabetes over 1 year;Ahrén;Diabetes Care,2005

2. The effects of dipeptidyl peptidase-4 inhibition on microvascular diabetes complications;Avogaro;Diabetes Care,2014

3. Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: targets for disease modification?;Bassil;Prog. Neurobiol.,2014

4. Beneficial effects of PKF275-055, a novel, selective, orally bioavailable, long-acting dipeptidyl peptidase IV inhibitor in streptozotocin-induced diabetic peripheral neuropathy;Bianchi;J. Pharmacol. Exp. Ther.,2012

5. Alpha-lipoic acid mitigates insulin resistance in Goto-Kakizaki rats;Bitar;Horm. Metab. Res.,2004

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ficus carica L. (Fig) promotes nerve regeneration in a mouse model of sciatic nerve crush;FEBS Open Bio;2024-06-28

2. Pathological evaluation of the pathogenesis of diabetes mellitus and diabetic peripheral neuropathy;Pathology International;2024-06-18

3. Proteomic changes related to actin cytoskeleton function in the skin of vildagliptin-treated mice;Journal of Dermatological Science;2024-03

4. How does diabetic peripheral neuropathy impact patients' burden of illness and the economy? A retrospective study in Beijing, China;Frontiers in Public Health;2023-05-12

5. Prevalence of Metabolic Syndrome in People with Type 2 Diabetes in Romania;Journal of Biosciences and Medicines;2023